Cargando…

Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion

Members of the tissue kallikrein‐related peptidase (KLK) family not only regulate several important physiological functions, but aberrant expression has also been associated with various malignancies. Clinically, KLKs have been suggested as promising biomarkers for diagnosis and prognosis in many ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delaunay, Tiphaine, Deschamps, Lydia, Haddada, Meriem, Walker, Francine, Soosaipillai, Antoninus, Soualmia, Feryel, El Amri, Chahrazade, Diamandis, Eleftherios P., Brattsand, Maria, Magdolen, Viktor, Darmoul, Dalila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623816/ https://www.ncbi.nlm.nih.gov/pubmed/28636767 http://dx.doi.org/10.1002/1878-0261.12103

Ejemplares similares

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis
por: Bouzid, Hayet, et al.
Publicado: (2022)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2019)

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
por: Patra, Kalicharan, et al.
Publicado: (2018)

Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury
por: Chen, Michelle, et al.
Publicado: (2019)

Structural basis for the Zn(2+) inhibition of the zymogen-like kallikrein-related peptidase 10
por: Debela, Mekdes, et al.
Publicado: (2016)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity
por: Skala, Wolfgang, et al.
Publicado: (2014)

Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
por: Ren, Annie, et al.
Publicado: (2021)

A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
por: Skala, Wolfgang, et al.
Publicado: (2016)

Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer
por: Pandey, Ritu, et al.
Publicado: (2021)

Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage
por: Martínez-Morillo, Eduardo, et al.
Publicado: (2012)

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002)

Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
por: Ren, Annie He, et al.
Publicado: (2020)

Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
por: Wang, Ping, et al.
Publicado: (2018)

Prognostic significance of multiple kallikreins in high-grade astrocytoma
por: Drucker, Kristen L., et al.
Publicado: (2015)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
por: Geng, Xiaocong, et al.
Publicado: (2017)

Secretome and degradome profiling shows that Kallikrein‐related peptidases 4, 5, 6, and 7 induce TGFβ‐1 signaling in ovarian cancer cells
por: Shahinian, Hasmik, et al.
Publicado: (2013)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
por: Makawita, Shalini, et al.
Publicado: (2013)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
por: Vilhelmsson Timmermand, O., et al.
Publicado: (2016)

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery
por: DORN, JULIA, et al.
Publicado: (2015)

Erratum: Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bcvmhodmp92uh9tuve9lgn279p